Hydrix Limited (ASX:HYD) | Remedy Robotics awards HYD A$3.4M Surgical Robotics Contract

Hydrix (ASX:HYD) has secured an engineering development contract with US based Remedy Robotics that is expected to generate approximately three point four million Australian dollars in revenue, recognised progressively during financial year twenty twenty-seven. In this episode, we examine the scope of the contract, its commercial significance based on the company's stated information, and what the expanded engineering role means for the ongoing development of Remedy's N One robotic platform.